BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,145 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,747,000 | +100.3% | 83,896 | +114.4% | 0.47% | +72.9% |
Q2 2020 | $3,369,000 | -4.1% | 39,133 | -9.6% | 0.27% | -22.7% |
Q1 2020 | $3,513,000 | -20.2% | 43,275 | -17.8% | 0.35% | +9.0% |
Q4 2019 | $4,402,000 | -4.6% | 52,637 | -0.2% | 0.32% | -12.7% |
Q3 2019 | $4,615,000 | +117.0% | 52,762 | +103.2% | 0.37% | +99.5% |
Q2 2019 | $2,127,000 | -55.4% | 25,969 | -55.8% | 0.19% | -57.1% |
Q1 2019 | $4,774,000 | -14.4% | 58,716 | -30.7% | 0.43% | -25.8% |
Q4 2018 | $5,580,000 | -54.8% | 84,771 | -47.1% | 0.58% | -49.5% |
Q3 2018 | $12,342,000 | -0.2% | 160,103 | -4.4% | 1.16% | -1.4% |
Q2 2018 | $12,365,000 | -8.3% | 167,458 | -19.2% | 1.18% | -11.5% |
Q1 2018 | $13,484,000 | -9.4% | 207,322 | -9.9% | 1.33% | -18.5% |
Q4 2017 | $14,880,000 | -0.2% | 230,203 | -3.1% | 1.63% | -9.3% |
Q3 2017 | $14,911,000 | +54.1% | 237,632 | +48.7% | 1.80% | +103.2% |
Q2 2017 | $9,674,000 | – | 159,792 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |